𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis

✍ Scribed by Vanesa Garcia; Jose M. Garcia; Javier Silva; Cristina Peña; Gemma Dominguez; Yolanda Lorenzo; Raquel Diaz; Isabel Alonso; Antonio Colas; Alicia Hurtado; Antonio Sanchez; Felix Bonilla

Book ID
106123876
Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
407 KB
Volume
134
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of plasma MMP-2 and MMP-9 levels as
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients
✍ Matthew G. Tutton; Mark L. George; Suzanne A. Eccles; Sarah Burton; R. Ian Swift 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 203 KB 👁 1 views

Matrix metalloproteinases, and notably the gelatinases MMP-2 and MMP-9, have important roles in tumour invasion, metastasis and angiogenesis. Our study investigates the distribution of MMP-2 and MMP-9 in colorectal cancer, the correlation with plasma levels, changes following surgical resection and

The course of galactose elimination capa
The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death
✍ C Merkel; G Marchesini; A Fabbri; S Bianco; G Bianchi; E Enzo; D Sacerdoti; M Zo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## ditions and in response to other treatments. (HEPATOL- There is increasing interest for the use of surrogate OGY 1996;24:820-823.) end points in the evaluation of treatments in patients with liver disease, but adequate validation is seldom Recent research in clinical epidemiology focused on th

Changes in tumor marker levels as a pred
Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma
✍ Bunzo Nakata; Kosei Hirakawa-Y. S. Chung; Kazuya Muguruma; Yoshito Yamashita; Th 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

## BACKGROUND. Evaluating chemotherapeutic effect in patients with gastric carcinoma sometimes is difficult. The authors investigated whether changes in the serum levels of three tumor markers can be used to predict the clinical outcome after chemotherapy. ## METHODS. Thirty patients with advance